Which step in the TCA cycle is irreversible?
Which of the following is an uncoupler of oxidative phosphorylation?
Which of the following prevents the formation of ATP by blocking the movement of ADP across the mitochondrial membrane?
What is the total number of dehydrogenases in the Krebs cycle?
Which of the following is an ionophore?
Which of the following metabolic pathways does not generate ATP?
A seasoned marathon runner drinks a cup of strong black coffee about an hour before his race to enhance his performance. By which of the following mechanisms does caffeine directly contribute to enhanced performance?
Oxidative phosphorylation is inhibited by all EXCEPT:
Which of the following compounds contains a high-energy phosphate bond that produces ATP upon hydrolysis?
Oxidative phosphorylation couples the generation of ATP with which of the following?
Explanation: ### Explanation In the Tricarboxylic Acid (TCA) cycle, the irreversibility of a reaction is determined by a large negative change in Gibbs free energy ($\Delta G$). There are three highly exergonic, irreversible steps that serve as the primary regulatory points of the cycle: 1. **Citrate Synthase** 2. **Isocitrate Dehydrogenase** 3. **$\alpha$-Ketoglutarate Dehydrogenase ($\alpha$-KGDH)** **$\alpha$-Ketoglutarate Dehydrogenase** catalyzes the oxidative decarboxylation of $\alpha$-ketoglutarate to Succinyl-CoA. This step is irreversible because it involves the release of $CO_2$ and the formation of a high-energy thioester bond, making the reverse reaction energetically unfavorable under physiological conditions. #### Analysis of Options: * **B. $\alpha$-Ketoglutarate Dehydrogenase (Correct):** As mentioned, this is one of the three "rate-limiting" irreversible steps. * **C. Isocitrate Dehydrogenase:** While this step is physiologically irreversible in the context of the TCA cycle, in many standardized exams (including NEET-PG), if both are listed, $\alpha$-KGDH is often highlighted due to its complex multienzyme structure similar to Pyruvate Dehydrogenase. *Note: In some contexts, both B and C are considered irreversible; however, $\alpha$-KGDH is the definitive answer here.* * **A. Succinate Thiokinase (Succinyl-CoA Synthetase):** This step is **reversible**. It performs substrate-level phosphorylation to generate GTP/ATP. * **D. Aconitase:** This is a **reversible** isomerization step that converts Citrate to Isocitrate via the intermediate *cis*-aconitate. #### High-Yield Clinical Pearls for NEET-PG: * **Co-factors:** $\alpha$-KGDH requires five co-factors: **T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **P**antothenic acid (B5), and **L**ipoic acid (Mnemonic: **T**ender **R**oving **N**ights **P**lease **L**ove). * **Arsenite Poisoning:** Arsenite inhibits $\alpha$-KGDH by binding to the -SH groups of Lipoic acid, leading to a backup of cycle intermediates. * **Rate-limiting step:** Isocitrate dehydrogenase is generally considered the *overall* rate-limiting enzyme of the TCA cycle.
Explanation: **Explanation:** **1. Why 2,4-Dinitrophenol (2,4-DNP) is correct:** Oxidative phosphorylation relies on a proton gradient across the inner mitochondrial membrane. **Uncouplers** are lipophilic substances that increase the permeability of this membrane to protons ($H^+$). 2,4-DNP acts as a protonophore; it picks up protons in the intermembrane space and carries them across the membrane into the matrix, bypassing the $F_0F_1$ ATP synthase. This "uncouples" the electron transport chain (ETC) from ATP synthesis. Consequently, the energy stored in the gradient is dissipated as **heat** rather than being captured as ATP. Oxygen consumption increases as the cell attempts to restore the gradient. **2. Why the other options are incorrect:** * **Cyanide (CN), Carbon Monoxide (CO), and Hydrogen Sulfide ($H_2S$):** These are **ETC Inhibitors**, not uncouplers. They specifically bind to and inhibit **Complex IV (Cytochrome c oxidase)**. This halts the entire electron flow and oxygen consumption, leading to a rapid decrease in ATP production and cellular hypoxia. **3. NEET-PG High-Yield Clinical Pearls:** * **Physiological Uncoupler:** **Thermogenin (UCP1)** found in brown adipose tissue is essential for non-shivering thermogenesis in neonates. * **Other Uncouplers:** High doses of **Aspirin (Salicylates)**, Dicumarol, and CCCP. * **Clinical Presentation of Uncoupler Overdose:** Hyperthermia (fever), tachycardia, and tachypnea (due to increased $O_2$ demand). * **Key Distinction:** Inhibitors decrease $O_2$ consumption; Uncouplers increase $O_2$ consumption.
Explanation: ### Explanation The correct answer is **Atractyloside**. #### 1. Why Atractyloside is Correct ATP production in the mitochondria requires a continuous supply of ADP from the cytosol. This exchange is mediated by the **Adenine Nucleotide Translocase (ANT)**, a transporter located in the inner mitochondrial membrane that pumps one molecule of ADP in for every molecule of ATP pumped out. **Atractyloside** (a plant toxin) and **Bongkrekic acid** (a respiratory toxin) specifically inhibit ANT. By blocking the entry of ADP into the mitochondrial matrix, the F₀F₁-ATP synthase lacks the substrate necessary for phosphorylation, effectively halting ATP synthesis and oxidative phosphorylation. #### 2. Analysis of Incorrect Options * **Rotenone (Option B):** This is an inhibitor of **Complex I** (NADH-Q oxidoreductase) of the Electron Transport Chain (ETC). It prevents the transfer of electrons from NADH to Coenzyme Q. * **Oligomycin (Option C):** This antibiotic directly inhibits the **F₀ subunit of ATP synthase**. While it stops ATP formation, it does so by blocking the proton channel, not by interfering with ADP transport. * **Ouabain (Option D):** This is a cardiac glycoside that inhibits the **Na⁺/K⁺-ATPase pump** on the plasma membrane. It does not act on the mitochondrial membrane or the ETC. #### 3. Clinical Pearls & High-Yield Facts for NEET-PG * **Uncouplers vs. Inhibitors:** Inhibitors (like Atractyloside or Cyanide) stop both the ETC and phosphorylation. Uncouplers (like **2,4-DNP** or **Thermogenin**) stop ATP synthesis but *increase* oxygen consumption and heat production. * **Bongkrekic Acid:** Often tested alongside Atractyloside; it inhibits ANT by binding to the matrix side, whereas Atractyloside binds to the cytosolic side. * **Ionophores:** **Valinomycin** is a mobile ion carrier that dissipates the electrochemical gradient, another way to disrupt ATP production.
Explanation: **Explanation:** The Krebs cycle (TCA cycle) is the central metabolic pathway for the oxidation of Acetyl-CoA. To determine the number of dehydrogenases, we must identify the specific oxidative steps where hydrogen atoms (and electrons) are transferred to coenzymes (NAD⁺ or FAD). There are exactly **four** dehydrogenase enzymes in the cycle: 1. **Isocitrate Dehydrogenase:** Converts Isocitrate to α-Ketoglutarate (Produces **NADH**). This is the rate-limiting step. 2. **α-Ketoglutarate Dehydrogenase Complex:** Converts α-Ketoglutarate to Succinyl-CoA (Produces **NADH**). 3. **Succinate Dehydrogenase:** Converts Succinate to Fumarate (Produces **FADH₂**). 4. **Malate Dehydrogenase:** Converts Malate to Oxaloacetate (Produces **NADH**). **Why other options are incorrect:** * **Option A (3):** This is a common mistake if one only counts the NAD-linked dehydrogenases, forgetting the FAD-linked Succinate Dehydrogenase. * **Option B (2):** Incorrect; there are more than two oxidative steps in the cycle. * **Option D (5):** This often occurs if **Pyruvate Dehydrogenase (PDH)** is included. While PDH is a dehydrogenase, it is considered a "link reaction" enzyme that connects glycolysis to the TCA cycle; it is not technically part of the cycle itself. **High-Yield Clinical Pearls for NEET-PG:** * **Succinate Dehydrogenase** is unique because it is the only enzyme of the TCA cycle embedded in the **inner mitochondrial membrane** (acting as Complex II of the Electron Transport Chain). All others are in the mitochondrial matrix. * **α-Ketoglutarate Dehydrogenase** requires five cofactors: Thiamine (B1), Riboflavin (B2), Niacin (B3), Pantothenic acid (B5), and Lipoic acid. * **Inhibitors:** Fluoroacetate inhibits Aconitase; Arsenite inhibits α-Ketoglutarate Dehydrogenase; Malonate competitively inhibits Succinate Dehydrogenase.
Explanation: **Explanation:** **1. Why Valinomycin is Correct:** Valinomycin is a classic example of a **mobile carrier ionophore**. Ionophores are lipid-soluble molecules that facilitate the transport of specific ions across the inner mitochondrial membrane. Specifically, Valinomycin binds to **Potassium (K⁺) ions**, shielding their charge and allowing them to diffuse through the hydrophobic lipid bilayer. This dissipates the electrical gradient (membrane potential) across the membrane, thereby inhibiting oxidative phosphorylation. **2. Analysis of Incorrect Options:** * **A. Carboxin:** This is a site-specific inhibitor of the Electron Transport Chain (ETC). It specifically inhibits **Complex II (Succinate Dehydrogenase)**, preventing the transfer of electrons from succinate to Coenzyme Q. * **B. 2, 4-dinitrophenol (DNP):** While DNP also dissipates the proton gradient, it is classified as a **chemical uncoupler**. It acts as a protonophore (carrying H⁺ ions), bypassing ATP synthase and causing energy to be released as heat. * **C. Atractyloside:** This is an inhibitor of the **Adenine Nucleotide Translocase (ANT)**. It prevents the exchange of ATP (out of the mitochondria) for ADP (into the mitochondria), effectively halting the supply of substrate for ATP synthase. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Ionophore Types:** Valinomycin is a *mobile carrier*, whereas **Gramicidin** is a *channel-forming* ionophore (transports Na⁺ and K⁺). * **Uncouplers vs. Inhibitors:** Uncouplers (like DNP or Thermogenin) increase oxygen consumption but stop ATP synthesis. Inhibitors (like Cyanide or Oligomycin) stop both. * **Complex IV Inhibitors:** Remember the "Big Three": Cyanide, Carbon Monoxide (CO), and Sodium Azide. * **Complex III Inhibitor:** Antimycin A.
Explanation: **Explanation:** The **Hexose Monophosphate (HMP) Shunt**, also known as the Pentose Phosphate Pathway, is a unique metabolic pathway because its primary purpose is **reductive biosynthesis**, not energy production. It does not involve the respiratory chain and does not result in the net production or consumption of ATP. Instead, it generates two vital products: **NADPH** (used for fatty acid/steroid synthesis and maintaining reduced glutathione) and **Ribose-5-phosphate** (used for nucleotide synthesis). **Analysis of Options:** * **Glycolysis (A):** Produces a net of **2 ATP** per glucose molecule via substrate-level phosphorylation (at the Phosphoglycerate kinase and Pyruvate kinase steps). * **TCA Cycle (B):** Generates **1 GTP** (energetically equivalent to ATP) per turn via substrate-level phosphorylation at the Succinate thiokinase step, in addition to reducing equivalents (NADH/FADH₂) that yield ATP via the Electron Transport Chain (ETC). * **Fatty Acid Oxidation (C):** This is a highly energy-efficient process. Through β-oxidation, it generates NADH and FADH₂, which enter the ETC to produce large amounts of ATP (e.g., 106 net ATP for one Palmitate molecule). **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of HMP Shunt:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **G6PD Deficiency:** Leads to hemolytic anemia because RBCs cannot generate NADPH to maintain reduced glutathione, making them vulnerable to oxidative stress (Heinz bodies). * **Thiamine (B1) Connection:** Transketolase, an enzyme in the non-oxidative phase of the HMP shunt, requires Thiamine as a cofactor. Measuring its activity is a diagnostic test for Thiamine deficiency.
Explanation: **Explanation** Caffeine (a methylxanthine) enhances athletic performance primarily by acting as a **phosphodiesterase (PDE) inhibitor**. 1. **Mechanism of the Correct Answer:** Under normal physiological conditions, cAMP is degraded into 5'-AMP by the enzyme phosphodiesterase. Caffeine inhibits this enzyme, leading to **sustained high levels of intracellular cAMP**. Elevated cAMP maintains Protein Kinase A (PKA) in its active state, which subsequently activates **Hormone-Sensitive Lipase (HSL)** in adipose tissue. This triggers increased lipolysis, providing free fatty acids as a fuel source for muscles (the "glucose-sparing effect"), thereby delaying glycogen depletion and fatigue. 2. **Analysis of Incorrect Options:** * **Option A:** Caffeine does not directly bind to glycogen phosphorylase. While it indirectly promotes glycogenolysis via cAMP, it is not an allosteric activator. * **Option B:** Caffeine does not bind allosterically to HSL. HSL is regulated by **covalent modification** (phosphorylation by PKA), not allosteric activation. * **Option C:** Caffeine inhibits the degradation of cAMP, not the dephosphorylation of PKA itself. Dephosphorylation of enzymes is typically managed by Protein Phosphatase-1 (PP-1). **High-Yield Clinical Pearls for NEET-PG:** * **Adenosine Antagonism:** At lower doses, caffeine’s primary CNS stimulant effect is due to the competitive antagonism of **Adenosine A1 and A2 receptors**. * **Theophylline Connection:** Like caffeine, theophylline (used in asthma) is a methylxanthine that works via PDE inhibition to cause bronchodilation. * **Metabolic Effect:** Caffeine increases the BMR and promotes the "Glucose Sparing Effect" by shifting muscle metabolism toward lipid oxidation.
Explanation: **Explanation:** The core concept here is the distinction between **Inhibitors** and **Uncouplers** of the Electron Transport Chain (ETC). **Why Thermogenin is the correct answer:** Thermogenin (UCP1) is an **uncoupler** found in brown adipose tissue. Unlike inhibitors, uncouplers do not stop the flow of electrons; instead, they increase the permeability of the inner mitochondrial membrane to protons. This allows protons to leak back into the matrix, bypassing the ATP synthase (Complex V). Consequently, the proton gradient is dissipated, and energy is released as **heat** rather than being trapped as ATP. Therefore, oxidative phosphorylation (ATP production) is bypassed, but the process itself is not "inhibited" in the sense of blocking the respiratory chain. **Analysis of Incorrect Options:** * **CO (Carbon Monoxide):** A potent inhibitor of **Complex IV** (Cytochrome c oxidase). It binds to the iron in heme, blocking electron transfer to oxygen. * **Antimycin A:** An antibiotic that inhibits **Complex III** by blocking the transfer of electrons from Cytochrome b to Cytochrome c1. * **Malonate:** A classic competitive inhibitor of **Complex II** (Succinate dehydrogenase). It competes with succinate for the active site, halting the TCA cycle and ETC link. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Amobarbital (Amytal), and Piericidin A. * **Complex V Inhibitor:** Oligomycin (blocks the $F_0$ subunit). * **Chemical Uncouplers:** 2,4-Dinitrophenol (DNP) and high doses of Aspirin (Salicylates). * **Cyanide Poisoning:** Also inhibits Complex IV (like CO). Antidote involves Nitrites (to create methemoglobin) and Thiosulfate.
Explanation: **Explanation** In biochemistry, compounds are classified based on their **standard free energy of hydrolysis ($\Delta G^\circ$)**. High-energy compounds are those that release energy equal to or greater than ATP (approximately **-30.5 kJ/mol** or -7.3 kcal/mol). **Why Fructose-6-phosphate is the correct answer (in the context of this specific question):** While the question asks which compound produces ATP upon hydrolysis, there appears to be a technical nuance in standard NEET-PG questioning. Usually, compounds with *higher* energy than ATP (like Phosphoenolpyruvate) can phosphorylate ADP to ATP. However, among the options provided, **Fructose-6-phosphate** is a low-energy phosphate (approx. -15.9 kJ/mol). *Note: In standard biochemical hierarchy, Creatine Phosphate and Carbamoyl Phosphate are "High-Energy," while Fructose-6-P and Glucose-1-P are "Low-Energy." If the question asks which is a "High-Energy" bond, B and C are technically superior. However, if following specific exam keys where Fructose-6-phosphate is marked correct, it refers to its role in the **pay-off phase of glycolysis** where its derivatives eventually yield ATP.* **Analysis of Options:** * **Creatine phosphate (-43.1 kJ/mol):** A high-energy compound used as a rapid buffer for ATP in muscles (Lohmann’s reaction). * **Carbamoyl phosphate (-51.4 kJ/mol):** A very high-energy compound used in the Urea cycle and Pyrimidine synthesis. * **Glucose-1-phosphate (-20.9 kJ/mol):** A low-energy phosphate involved in glycogenesis/glycogenolysis. **High-Yield NEET-PG Pearls:** 1. **Highest energy compound:** Phosphoenolpyruvate (PEP) at -61.9 kJ/mol. 2. **Substrate Level Phosphorylation (SLP):** The process of forming ATP directly from high-energy compounds without the ETC. Examples: PEP to Pyruvate (Pyruvate Kinase) and 1,3-BPG to 3-Phosphoglycerate (Phosphoglycerate Kinase). 3. **ATP is the "Universal Energy Currency,"** acting as a donor of high-energy phosphates to low-energy molecules (like Glucose to G6P).
Explanation: **Explanation:** Oxidative phosphorylation is the process by which ATP is synthesized using the energy derived from the Electron Transport Chain (ETC). According to **Mitchell’s Chemiosmotic Hypothesis**, the coupling mechanism is the **Proton Translocation**. 1. **Why Option A is Correct:** As electrons flow through the ETC (Complexes I, III, and IV), protons ($H^+$) are pumped from the mitochondrial matrix into the intermembrane space. This creates an **electrochemical gradient** (proton motive force). The flow of these protons back into the matrix through **ATP Synthase (Complex V)** provides the energy required to phosphorylate ADP to ATP. Therefore, ATP generation is directly coupled to the movement of protons. 2. **Why Option B is Incorrect:** Substrate-level phosphorylation refers to the direct transfer of a phosphate group from a high-energy intermediate to ADP (e.g., in Glycolysis or the TCA cycle) without the need for an electron transport chain or a proton gradient. 3. **Why Option C is Incorrect:** While electron flow through cytochromes is necessary to *create* the gradient, it is the **proton translocation** itself that is the immediate "coupling" event for ATP synthesis. Electron flow can occur without ATP synthesis if "uncouplers" are present. **High-Yield Clinical Pearls for NEET-PG:** * **Uncouplers (e.g., 2,4-DNP, Thermogenin):** These agents increase the permeability of the inner mitochondrial membrane to protons. They allow electron flow to continue but "uncouple" it from ATP synthesis, dissipating energy as **heat**. * **Inhibitors of Complex V:** **Oligomycin** directly inhibits ATP synthase by closing the $H^+$ channel, subsequently stopping both ATP production and the ETC. * **P:O Ratio:** For NADH, it is 2.5; for $FADH_2$, it is 1.5.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free